Figure_3.tif (2.04 MB)
Western blot analysis confirms FLT3 inhibitor responsive pTyr-sites in AML cell lines.
figure
posted on 2011-04-28, 02:44 authored by Ting-lei Gu, Julie Nardone, Yi Wang, Marc Loriaux, Judit Villén, Sean Beausoleil, Meghan Tucker, Jon Kornhauser, Jianmin Ren, Joan MacNeill, Steven P. Gygi, Brian J. Druker, Michael C. Heinrich, John Rush, Roberto D. Polakiewicz(A), (B), (C), and (D) Immunoblotting of MV(4,11) and Molm 14 cells treated with 2 uM FLT3 inhibitor (MLN518) for 2 hours with different phospho-specific antibodies. HEL and K562 cells were included as controls.
